TGFB1 and cancer: Therefore, aberrant activity of the TGFβ signaling pathway, in the vast majority of solid tumors, could be functionally linked to the development and maintenance of cancer stem cells, further supporting the notion that this pathway may represent an attractive target for cancer therapy.